rxstatShortages › Prazosin

Prazosin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Prazosin products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 20, 2026.

An alpha blocker used to treat high blood pressure and PTSD-related nightmares.

Products affected
2 / 6
In shortage since
Jun 2, 2026
Est. full return
Aug 20, 2026
Reports on file
31
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
APO-PRAZO
1MG · TABLET · APOTEX INC
DIN 00882801 · since Jun 2, 2026, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-PRAZOSIN
1MG · TABLET · TEVA CANADA LIMITED
DIN 01934198 · since Jun 10, 2026, est. end Aug 20, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PRAZO
1MG · TABLET · APOTEX INC
DIN 00882801 · ended Mar 19, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-PRAZOSIN
5MG · TABLET · TEVA CANADA LIMITED
DIN 01934228 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-PRAZOSIN
1MG · TABLET · TEVA CANADA LIMITED
DIN 01934198 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-PRAZOSIN
2MG · TABLET · TEVA CANADA LIMITED
DIN 01934201 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-PRAZOSIN
1MG · TABLET · TEVA CANADA LIMITED
DIN 01934198 · ended May 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-PRAZOSIN
2MG · TABLET · TEVA CANADA LIMITED
DIN 01934201 · ended May 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-PRAZOSIN
5MG · TABLET · TEVA CANADA LIMITED
DIN 01934228 · ended May 31, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-PRAZO TAB 1MG
1MG · TABLET · APOTEX INC
DIN 00882801 · ended Jan 24, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-PRAZO TAB 5MG
5MG · TABLET · APOTEX INC
DIN 00882836 · ended Jan 24, 2025 · Shortage of an active ingredient.
Resolved
APO-PRAZO TAB 2MG
2MG · TABLET · APOTEX INC
DIN 00882828 · ended Jan 24, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 31 reports. All reports are on file with Health Canada.

What's happening

Prazosin is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Prazosin is classified under “ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING” (ATC C02CA).

Recent changes

Common questions

What is Prazosin used for?

An alpha blocker used to treat high blood pressure and PTSD-related nightmares.

When will Prazosin be back in stock in Canada?

The latest manufacturer estimate is Aug 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Prazosin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiadrenergic agents, peripherally acting)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.